Roche, Exelixis’ Drug Combo Bounces Back with Late-Stage Prostate Cancer Win 8/21/2023

Moderna, CARsgen Join Forces Combining mRNA Cancer Vaccine with CAR T 8/21/2023

Regeneron Expands Eylea’s Label with High-Dose Approval 8/21/2023

CRISPR Shows Preclinical Promise in Treating Alzheimer’s, Challenges Persist 8/21/2023

FDA Pilot Program for Cancer Diagnostics Met with Skepticism 8/21/2023

AbbVie (NYSE: ABBV) announced that the European Commission has approved AQUIPTA® (atogepant) for the prophylaxis of migraine in adults who have four or more migraine days per month. The approval makes AQUIPTA the first and only once-daily oral calcitonin gene-related peptide (CGRP) receptor antagonist (gepant) treatment in the European Union for the preventive treatment of both chronic and episodic migraine.

People who adhere to a Mediterranean lifestyle - which includes a diet rich in fruits, vegetables, and whole grains; healthy eating habits like limiting added salts and sugars; and habits promoting adequate rest, physical activity, and socialization - have a lower risk of all-cause and cancer mortality, according to a new study led by La Universidad Autónoma de Madrid and Harvard T.H. Chan School of Public Health.

Selecta Biosciences Halts Pipeline Investments, Focuses on Gout Treatment 8/17/2023

Boehringer Initiates Phase III Obesity Trials, Seeks to Challenge Novo and Lilly 8/17/2023

FDA Approves Ipsen’s Palovarotene for Ultra-Rare Bone Disease 8/17/2023

Federal Appeals Court Rules for Tighter Restrictions on Abortion Pill 8/17/2023

Chimerix’s Drug Candidate Improves Survival for Patients with Incurable Brain Tumor 8/17/2023

Incubators Offer Staffing Support for Startups 8/17/2023

Dr. Heather Sandison, a leading expert in Alzheimer's Disease and Related Dementia (ADRD) care, has recently published a groundbreaking study in the Journal of Alzheimer's Disease, highlighting significant improvements in cognitive function among individuals with cognitive decline. The study is the second to employ a multimodal, individualized care plan and offers further hope for managing and potentially reversing cognitive impairment.

How to Start an Employee Resource Group at Work 8/16/2023

Equipping cancer-infecting, or oncolytic, viruses with tumor-inhibiting genetic cargo stimulates the immune system and helps immunotherapy to shrink or completely clear aggressive tumors in mice, according to a new study in the Journal of Experimental Medicine led by University of Pittsburgh and UPMC researchers. The results pave the way for clinical trials combining oncolytic viruses with immunotherapy.

Pfizer Bispecific Drug Wins FDA Accelerated Approval for Multiple Myeloma 8/15/2023

Galecto Drops Idiopathic Pulmonary Fibrosis Hopeful After Phase II Flop 8/15/2023

Design Therapeutics Stock Plunges Amid Redesign of Only Clinical Asset 8/15/2023

Harmony Makes Rare Disease Play with Potential $200M Zynerba Buyout 8/15/2023